SRX HEALTH SOLUTIONS INC (SRXH)
AMEXConsumer StaplesSoftware - ApplicationSnapshot 2026-09-04
$1.51-3.21%
Close 2026-09-04 · 1-day change
AMEXConsumer StaplesSoftware - ApplicationSnapshot 2026-09-04
QuarterlyIQ Insights · SRXH
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits well below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 10.6% |
| Our one-year growth estimate | diamond | Not available |
Growth built into the price is above our model estimate.
A comparable growth gap is not available.
The one-year revenue growth assumption on Valuation.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Elevated risk of a next-quarter earnings miss: this name is on a run of consecutive earnings misses and has been missing across recent quarters. A fundamental tilt, not a price call.
Model as of 2026-09-04 · Compared with 120 industry peers · Company calendar date is not available
SRXH — capital allocation — Unregistered Sales of Equity Securities
Dated 2026-08-28
Unregistered Sales of Equity Securities. The information provided in
Why it matters: Keeping revenue growth is important for SRXH's long-term success in a changing market.
Watch forRevenue increases to over $4M in the next quarter.
Also watch forRevenue declines further below $3M in the next quarter.
Why it matters: Sales growth shows the company's recovery and strength.
Worry ifQ3 net sales growth below 27% year over year.
Less concerning ifQ3 net sales growth meets or exceeds 27% year over year.
Why it matters: A successful buyback shows management's confidence. It may help the share price.
Supportive ifThey announced a buyback of at least 1 million shares.
Worry ifNo big buyback activity was reported in the next quarter.
Why it matters: Regaining compliance is key for keeping investor trust and access to the market.
Supportive ifSRXH meets NYSE standards and has no new deficiency notices.
Worry ifNew notices of non-compliance from NYSE are issued.
Why it matters: Revenue growth shows the acquisition is going well. This can help investor feelings.
Supportive ifRevenue exceeds $3.4 million in Q3. This shows the acquisition is working.
Worry ifRevenue fails to grow or declines from $3.4 million.
Why it matters: Good performance from EMJX can help SRX's investment plan. It can also boost investor trust.
Supportive ifEMJX reports returns above 25% from February 11, 2026, to the next quarterly update.
Worry ifEMJX performance falls below 10% return during the same period.
Why it matters: Lawsuits can hurt financial health and management focus. They may affect stock value.
Worry ifThe company reports a good outcome in the lawsuit.
Less concerning ifThe lawsuit worsens or causes financial problems.
Why it matters: Better operating income means the company is losing less money. This helps future growth.
Supportive ifOperating income goes above -$1.8 million in Q3.
Worry ifOperating income gets worse or stays below -$1.8 million.
Why it matters: Maintaining compliance is crucial for SRXH's listing status and investor trust.
Supportive ifNo new notices of non-compliance from NYSE in the next quarter.
Worry ifNew notice of non-compliance from NYSE within the next quarter.
Why it matters: Starting live trading shows the company is serious about growth. It could increase revenue.
Supportive ifThe company announces that live trading with real money has started for the EMJX strategy.
Worry ifThe company delays or cancels the launch of live trading for the EMJX strategy.
Why it matters: Stable revenue growth signals the company is recovering from past losses. It shows progress in enhancing revenue growth.
Supportive ifQ3 revenue was over $3 million. This shows the company is recovering.
Worry ifQ3 revenue falls below $3 million, showing a setback in growth.
Why it matters: Better operations can help gain more customers and increase revenue.
Supportive ifHalo has fill rates over 95%. Year-over-year growth in New-to-Brand customers is over 15%.
Worry ifFill rates drop below 90% or New-to-Brand customer growth is less than 10%.
Why it matters: The trial's progress is important for CERo's main therapy, CER-1236. It treats blood cancers.
Supportive ifThe third cohort of the CERTAIN-T trial successfully enrolls patients and begins treatment.
Worry ifThe trial faces delays or fails to enroll patients for the third cohort.
Why it matters: The buyback program could signal confidence in the company's value and support share price.
Supportive ifThe company shows good progress in its buyback program. It is reducing shares available.
Worry ifThe buyback program fails to reduce shares outstanding or is halted.
Why it matters: If EMJX is integrated well, it could improve SRX's investment skills and performance.
Supportive ifManagement says EMJX's AI insights improved performance in six months.
Worry ifIntegration problems lead to no clear gains in investment performance.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$388 on $10,000 · ±3.9% | How much price usually moves either way. |
| Bad day | $1,587 loss on $10,000 · 15.9% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $8,444 loss on $10,000 · 84.4% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.